Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

Institute of Tropical Medecine, Antwerp

St Pierre University Hospital, Brussels

CHU Hotel Dieu, Nantes

Hospital Saint Louis, Paris

Pitié-salpêtrière Hospital, Paris

University Bonn, Bonn

University Essen, Essen

Frankfurt University Hospital, Frankfurt

ICH Study Center, Hamburg, Hamburg

AAST delgi spedali civili di Brescia, Brescia

ASST FBF SACCO- I Division of Infectious Diseases 1, Milan

ASST FBF SACCO- I Division of Infectious Diseases 3, Milan

I.R.C.C.S San Raffaele Hospital, Milan

ASST GOM Niguarda Milano, Dep. Infectious Disease, Milan

Hospital General Universitario de Alicante, Alicante

Hospital Clínic de Barcelona, Barcelona

Hospital Universitari Vall d'Herbo, Barcelona

Infectious Diseases Unit Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital General Universitario de Elche, Elche

Hospital Universitario La Paz, Madrid, Madrid

Brighton & Sussex University NHS Trust, Brighton

North Bristol NHS Trust, Southmead Hospital, Bristol

Chelsea & Westminster Hospital, London

Kings College Hospital London, London

Mortimer Market Centre, London

Queen Elizabeth Hospital, London

Royal Free London NHS Foundation Trust, London

St Marys Hospital, London

The Royal London Hospital, London